查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1964006

醫藥協作機器人市場－全球產業規模、佔有率、趨勢、機會、預測：按應用、最終用途、地區和競爭格局分類，2021-2031年

Pharmaceutical Collaborative Robots Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫藥協作機器人市場預計將從 2025 年的 7,912 萬美元成長到 2031 年的 1.3445 億美元，複合年成長率為 9.24%。

這些協作機器人是專門設計的自動化系統，旨在與人類工人在共用環境中安全協作，並擴大承擔諸如無菌配製、包裝和實驗室分析等任務。推動這一成長的因素包括：在高精度環境中減少人為錯誤、滿足對無污染生產區域的需求以及解決技術純熟勞工短缺問題。除了這些技術趨勢之外，營運因素也反映了該行業對效率和安全性的需求。例如，國際機器人聯合會 (IFR) 報告稱，到 2024 年，診斷和醫療檢測機器人的銷售將增加 610%，這反映了對自動化的依賴。

市場概覽
預測期 2027-2031
市場規模：2025年 7912萬美元
市場規模：2031年 1.3445億美元
複合年成長率：2026-2031年 9.24%
成長最快的細分市場 揀貨和包裝
最大的市場 北美洲

儘管存在這些成長要素，但監管製藥生產的嚴格合規環境對市場擴張構成了重大障礙。全球衛生監管機構強制執行嚴格的藥品生產品質管理通訊協定(GMP)，要求對新引入的自動化設備進行大量的文件記錄和測試。這種複雜的檢驗流程通常會導致更長的部署週期和更高的實施成本，對那些希望將這些協作系統整合到檢驗的工作流程中的公司而言，構成了一項重大挑戰。

市場促進因素

對營運效率和高通量自動化的需求是推動市場成長的主要動力，製藥公司正積極採用協作機器人來簡化複雜的生產流程，例如細胞療法生產。這種轉變不僅限於速度提升，更著眼於在個人化醫療生產中實現顯著的成本降低。例如，Universal Robots 於 2025 年 8 月發布的一份題為《機器人技術變革細胞療法》的案例研究指出，引入用於生物製造的新型機器人叢集，與人工操作相比，可使運營成本降低 74%，並大幅提高產能。

此外，為最大限度減少關鍵操作和品管環節中的人為錯誤，協作機器人的應用正在加速普及。在監管嚴格的製藥行業，保持無菌和零缺陷生產至關重要，而協作機器人能夠以極高的精度執行重複性、高精度任務，從而滿足這些需求。這種能力對於降低污染風險和提高產品安全性至關重要。如同2025年2月發表於《機器人未來》（RoboticsTomorrow）雜誌的報導《製藥機器人的崛起》所述，將自動化引入製藥生產可以將產品瑕疵減少高達80%。為了反映這一發展勢頭，自動化協會（AAA）指出，2025年第二季生命科學和製藥業的機器人訂單增了22%。

市場挑戰

製藥業嚴格的監管環境是協作機器人市場成長的主要阻礙因素。這些自動化系統必須符合嚴格的藥品生產品質管理規範 (GMP)，因為它們直接接觸敏感的藥品和關鍵的生產流程。這項要求需要完善的檢驗通訊協定，包括安裝資格確認(IQ)、運作資格確認(OQ) 和效能資格確認(PQ)，以徹底消除錯誤和污染的風險。這種全面的文件記錄和測試要求顯著增加了實施成本，並延長了新設備的部署時間。這往往會延遲投資回報，並阻礙協作系統的快速部署。

鑑於該行業對自動化日益成長的需求，這項監管瓶頸尤為重要。根據自動化促進協會（Association for Advancing Automation）的數據顯示，2024年生命科學、製藥和生物醫學產業的機器人訂單激增46%。儘管採購量的成長顯示了對自動化應用的堅定承諾，但複雜且往往延誤的核准流程限制了這些資產運作，從而減緩了市場的實際成長速度。

市場趨勢

在細胞療法和基因療法等先進治療藥物（ATMP）的快速發展推動下，小批量個人化醫療的自動化配藥正成為一種變革性趨勢。與傳統的大規模生產不同，這些治療方法需要在嚴格的無菌條件下處理患者特異性生物材料。協作機器人在這方面表現出色，它們在隔離屏障系統內運行，並且能夠比人工操作更穩定地進行精細的液體處理，從而確保無菌並維護身份鏈。安川電機株式會社與Astellas製藥於2024年5月簽署的夥伴關係合作備忘錄，清楚體現了對自動化個人化醫療的重視。該備忘錄旨在共同開發一個整合機器人技術的細胞治療生態系統，以實現高精度流程的標準化。

同時，製藥業正朝著模組化和可重構的生產單元方向發展，尤其是在包裝和套件組裝流程中。製藥公司正在加速用靈活的協作機器人單元取代僵化的、單一用途的自動化生產線，這些協作機器人單元能夠快速響應頻繁的產品切換和多樣​​化的包裝形式。這種模組化設計能夠有效管理多品種、小批量生產，隨著產品生命週期縮短和SKU複雜性增加，這一點變得愈發重要。美國自動化協會 (AAA) 最新發布的《2025年第一季北美機器人訂單趨勢》報告的數據也反映了對這些高度適應性解決方案的需求。報告顯示，光是2025年第一季，生命科學、製藥和生物醫學領域就訂單了127台協作機器人。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：製藥業協作機器人的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按應用領域（揀貨和包裝、藥物測試、實驗室用途）
    • 依最終用戶（製藥公司、研究機構等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美製藥業協作機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲製藥業協作機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區製藥協作機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲製藥產業協作機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲製藥協作機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球製藥協作機器人市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • ABB Ltd
  • Universal Robots A/S
  • Mitsubishi Electric Corporation
  • KUKA AG
  • Kawasaki Heavy Industries Ltd
  • Yaskawa Electric Corporation
  • DENSO Wave Inc
  • FANUC Corporation
  • Omron Corporation
  • Seiko Epson Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 21982

The Global Pharmaceutical Collaborative Robots Market is projected to expand from USD 79.12 Million in 2025 to USD 134.45 Million by 2031, registering a CAGR of 9.24%. These collaborative robots are specialized automated systems engineered to function safely alongside human workers in shared environments, increasingly handling tasks such as sterile compounding, packaging, and laboratory analysis. Growth is fundamentally supported by the urgent need to reduce human error in high-precision settings, the demand for contamination-free manufacturing areas, and the necessity to offset skilled labor shortages. These operational drivers, distinct from purely technological trends, emphasize the industry's need for efficiency and safety. Illustrating this reliance on automation, the International Federation of Robotics reported a 610% increase in sales of robots for diagnostics and medical laboratory analysis in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 79.12 Million
Market Size 2031USD 134.45 Million
CAGR 2026-20319.24%
Fastest Growing SegmentPicking and Packaging
Largest MarketNorth America

Despite these drivers, the rigorous regulatory compliance landscape governing pharmaceutical production poses a significant obstacle to broader market expansion. Global health authorities enforce stringent Good Manufacturing Practice protocols, which mandate extensive documentation and testing for any new automated machinery. This complex validation process frequently leads to prolonged deployment timelines and escalated implementation costs, presenting a substantial barrier for companies seeking to incorporate these collaborative systems into validated workflows.

Market Driver

The necessity for operational efficiency and high-throughput automation serves as a primary engine for market growth, prompting pharmaceutical manufacturers to aggressively adopt collaborative robots for streamlining complex workflows like cell therapy production. This transition moves beyond mere speed, focusing on achieving significant cost reductions in personalized medicine manufacturing. For instance, a case study titled 'Robotics transforms cell therapy' by Universal Robots in August 2025 highlighted that deploying a new robotic cluster for biomanufacturing resulted in a 74% decrease in operational costs while substantially boosting production capacity compared to manual techniques.

Additionally, the drive to minimize human error in critical handling and quality control tasks fuels widespread adoption. In the highly regulated pharmaceutical industry, maintaining sterile conditions and ensuring zero-defect outputs are essential, and cobots address these needs by executing repetitive, high-precision tasks with unwavering accuracy. This capability is vital for mitigating contamination risks and improving product safety. As reported by RoboticsTomorrow in the February 2025 article 'The Rise of Pharma Robots,' integrating automation in drug manufacturing can reduce product defects by up to 80%. Mirroring this momentum, the Association for Advancing Automation noted a 22% increase in robot orders from the life sciences and pharmaceutical sector during the second quarter of 2025 compared to the prior year.

Market Challenge

The strict regulatory compliance landscape within pharmaceutical production serves as a major restraint on the collaborative robots market's growth. Since these automated systems interact directly with sensitive drug products and essential manufacturing processes, they must adhere to rigorous Good Manufacturing Practice standards. This requirement necessitates exhaustive validation protocols, including Installation, Operational, and Performance Qualifications, to guarantee zero risk of error or contamination. The need for such comprehensive documentation and testing considerably increases implementation costs and prolongs the time required to deploy new machinery, often delaying returns on investment and discouraging the rapid integration of collaborative systems.

This regulatory bottleneck is especially significant given the rising demand for automation in the sector. According to the Association for Advancing Automation, robot orders from the life sciences, pharmaceutical, and biomedical industries surged by 46% in 2024. Although this increase in procurement demonstrates a strong intent to adopt automation, the complex and slow approval framework limits the pace at which these assets can be brought online, effectively slowing the market's realized growth rate.

Market Trends

The deployment of automation in small-batch personalized medicine compounding is emerging as a transformative trend, fueled by the growth of Advanced Therapy Medicinal Products such as cell and gene therapies. Unlike traditional bulk manufacturing, these treatments demand the handling of patient-specific biological materials under strictly aseptic conditions. Collaborative robots are uniquely capable in this area, operating within isolated barrier systems to execute delicate liquid handling with greater consistency than human operators, thereby ensuring sterility and maintaining the chain of identity. This focus on automated personalized care is highlighted by Yaskawa Electric Corporation's May 2024 announcement regarding the 'Astellas Pharma Partnership,' where a memorandum of understanding was signed to co-develop a cell therapy ecosystem integrating robotics to standardize high-precision processes.

Simultaneously, the industry is shifting towards modular and reconfigurable manufacturing cells, particularly for packaging and kitting operations. Pharmaceutical manufacturers are increasingly replacing rigid, single-purpose automation lines with flexible cobot cells capable of adapting quickly to frequent product changeovers and diverse packaging formats. This modularity enables facilities to efficiently manage high-mix, low-volume production runs, which is critical as product lifecycles shorten and SKU complexity rises. The demand for such adaptable solutions is reflected in recent data from the Association for Advancing Automation's 'Q1 2025 North American Robot Orders' report, which noted that the Life Sciences, Pharmaceutical, and Biomedical sector ordered 127 collaborative robot units in the first quarter of 2025 alone.

Key Market Players

  • ABB Ltd
  • Universal Robots A/S
  • Mitsubishi Electric Corporation
  • KUKA AG
  • Kawasaki Heavy Industries Ltd
  • Yaskawa Electric Corporation
  • DENSO Wave Inc
  • FANUC Corporation
  • Omron Corporation
  • Seiko Epson Corporation

Report Scope

In this report, the Global Pharmaceutical Collaborative Robots Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Collaborative Robots Market, By Application

  • Picking and Packaging
  • Inspection of Pharmaceutical Drugs
  • Laboratory Applications

Pharmaceutical Collaborative Robots Market, By End-use

  • Pharmaceutical Companies
  • Research Laboratories
  • Others

Pharmaceutical Collaborative Robots Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Collaborative Robots Market.

Available Customizations:

Global Pharmaceutical Collaborative Robots Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Collaborative Robots Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Picking and Packaging, Inspection of Pharmaceutical Drugs, Laboratory Applications)
    • 5.2.2. By End-use (Pharmaceutical Companies, Research Laboratories, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Pharmaceutical Collaborative Robots Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmaceutical Collaborative Robots Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada Pharmaceutical Collaborative Robots Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico Pharmaceutical Collaborative Robots Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By End-use

7. Europe Pharmaceutical Collaborative Robots Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pharmaceutical Collaborative Robots Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End-use
    • 7.3.2. France Pharmaceutical Collaborative Robots Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom Pharmaceutical Collaborative Robots Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy Pharmaceutical Collaborative Robots Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain Pharmaceutical Collaborative Robots Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By End-use

8. Asia Pacific Pharmaceutical Collaborative Robots Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pharmaceutical Collaborative Robots Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End-use
    • 8.3.2. India Pharmaceutical Collaborative Robots Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan Pharmaceutical Collaborative Robots Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea Pharmaceutical Collaborative Robots Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia Pharmaceutical Collaborative Robots Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End-use

9. Middle East & Africa Pharmaceutical Collaborative Robots Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pharmaceutical Collaborative Robots Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE Pharmaceutical Collaborative Robots Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa Pharmaceutical Collaborative Robots Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End-use

10. South America Pharmaceutical Collaborative Robots Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pharmaceutical Collaborative Robots Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia Pharmaceutical Collaborative Robots Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina Pharmaceutical Collaborative Robots Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pharmaceutical Collaborative Robots Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ABB Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Universal Robots A/S
  • 15.3. Mitsubishi Electric Corporation
  • 15.4. KUKA AG
  • 15.5. Kawasaki Heavy Industries Ltd
  • 15.6. Yaskawa Electric Corporation
  • 15.7. DENSO Wave Inc
  • 15.8. FANUC Corporation
  • 15.9. Omron Corporation
  • 15.10. Seiko Epson Corporation

16. Strategic Recommendations

17. About Us & Disclaimer